In the last 12 months, insiders at Editas Medicine, Inc. ($EDIT) filed 105 transactions with the SEC: 1 open-market purchases totaling $253,868 and 47 sales totaling $1,613,615. Net insider sentiment: net selling.
Editas Medicine, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- O'Neill Gilmore Neil (CEO) — 19 transactions totaling $962,329
- Hopfield Jessica (Director) — 3 transactions totaling $253,868
- Mei Baisong (SVP, CHIEF MEDICAL OFFICER) — 8 transactions totaling $229,415
- Lucera Erick (EVP, CHIEF FINANCIAL OFFICER) — 9 transactions totaling $132,434
- Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) — 15 transactions totaling $88,215
View all SEC Filings for Editas Medicine, Inc. (EDIT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | O'Neill Gilmore Neil | CEO | A | Stock Option (right to buy) | 1015200 | $0.00 | 1,015,200.0000 | 97,618,660 | 9999.99% | 1.04% |
| March 12, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 292856 | $0.00 | 292,856.0000 | 97,618,660 | 9999.99% | 0.30% |
| March 12, 2026 | Parison Amy | SVP, Chief Financial Officer | A | Stock Option (right to buy) | 292856 | $0.00 | 292,856.0000 | 97,618,660 | 9999.99% | 0.30% |
| March 3, 2026 | O'Neill Gilmore Neil | CEO | S | Common Stock | 5394 | $2.02 | 263,693.0000 | 97,618,660 | 2.00% | 0.01% |
| March 3, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 749 | $2.02 | 68,028.0000 | 97,618,660 | 1.09% | 0.00% |
| March 3, 2026 | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 474 | $2.02 | 15,434.0000 | 97,618,660 | 2.98% | 0.00% |
| Dec. 3, 2025 | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 461 | $2.15 | 15,908.0000 | 97,618,660 | 2.82% | 0.00% |
| Dec. 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 713 | $2.15 | 68,777.0000 | 97,618,660 | 1.03% | 0.00% |
| Dec. 3, 2025 | O'Neill Gilmore Neil | CEO | S | Common Stock | 5603 | $2.15 | 269,087.0000 | 97,618,660 | 2.04% | 0.01% |
| Sept. 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 710 | $2.60 | 69,490.0000 | 82,976,284 | 1.01% | 0.00% |
| Sept. 3, 2025 | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 458 | $2.60 | 16,369.0000 | 82,976,284 | 2.72% | 0.00% |
| Sept. 3, 2025 | O'Neill Gilmore Neil | CEO | S | Common Stock | 5592 | $2.60 | 274,690.0000 | 82,976,284 | 2.00% | 0.01% |
| Aug. 7, 2025 | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 679 | $2.58 | 16,827.0000 | 82,976,284 | 3.88% | 0.00% |
| July 31, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 5121 | $2.49 | 64,398.0000 | 82,976,284 | 7.37% | 0.01% |
| June 6, 2025 | Levy Elliott M. | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 6, 2025 | Connaughton Bernadette | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 6, 2025 | Hirsch Andrew | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 6, 2025 | Scadden David | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 6, 2025 | Hopfield Jessica | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 3, 2025 | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 446 | $1.72 | 17,506.0000 | 82,976,284 | 2.48% | 0.00% |
| June 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 726 | $1.72 | 69,519.0000 | 82,976,284 | 1.03% | 0.00% |
| June 3, 2025 | O'Neill Gilmore Neil | CEO | S | Common Stock | 15192 | $1.72 | 280,282.0000 | 82,976,284 | 5.14% | 0.02% |
| April 8, 2025 | Parison Amy | SVP, Chief Financial Officer | A | Stock Option (right to buy) | 34672 | $0.00 | 34,672.0000 | 82,976,284 | 9999.99% | 0.04% |
| March 8, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 275100 | $0.00 | 275,100.0000 | 82,976,284 | 9999.99% | 0.33% |
| March 8, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 82,976,284 | 9999.99% | 0.08% |
| March 8, 2025 | O'Neill Gilmore Neil | CEO | A | Stock Option (right to buy) | 828000 | $0.00 | 828,000.0000 | 82,976,284 | 9999.99% | 1.00% |
| March 8, 2025 | O'Neill Gilmore Neil | CEO | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 82,976,284 | 9999.99% | 0.21% |
| March 8, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 275100 | $0.00 | 275,100.0000 | 82,976,284 | 9999.99% | 0.33% |
| March 8, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 82,976,284 | 9999.99% | 0.08% |
| March 4, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2891 | $1.71 | 70,245.0000 | 82,976,284 | 3.95% | 0.00% |
| March 4, 2025 | O'Neill Gilmore Neil | CEO | S | Common Stock | 16632 | $1.71 | 295,474.0000 | 82,976,284 | 5.33% | 0.02% |
| March 4, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 4109 | $1.71 | 112,720.0000 | 82,976,284 | 3.52% | 0.00% |
| Dec. 3, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S | Common Stock | 541 | $2.08 | 133,354.0000 | 0 | 0.40% | 0.00% |
| Dec. 3, 2024 | O'Neill Gilmore Neil | CEO | S | Common Stock | 1618 | $2.08 | 312,106.0000 | 0 | 0.52% | 0.00% |
| Sept. 4, 2024 | O'Neill Gilmore Neil | CEO | S | Common Stock | 1555 | $3.42 | 313,724.0000 | 0 | 0.49% | 0.00% |
| Sept. 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S | Common Stock | 518 | $3.42 | 133,895.0000 | 0 | 0.39% | 0.00% |
| July 25, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 11886 | $5.42 | 73,136.0000 | 0 | 13.98% | 0.00% |
| July 19, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S | Common Stock | 6619 | $5.21 | 134,413.0000 | 0 | 4.69% | 0.00% |
| June 4, 2024 | O'Neill Gilmore Neil | CEO | S | Common Stock | 12191 | $5.50 | 315,279.0000 | 0 | 3.72% | 0.00% |
| June 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S | Common Stock | 511 | $5.50 | 141,032.0000 | 0 | 0.36% | 0.00% |
| May 30, 2024 | Scadden David | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Chatterjee Meeta | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Hirsch Andrew | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Reeve Emma | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Levy Elliott M. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Connaughton Bernadette | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Vaishnaw Akshay | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Hopfield Jessica | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 22337 | $5.61 | 116,829.0000 | 0 | 16.05% | 0.00% |
| May 13, 2024 | Hopfield Jessica | Director | P | Common Stock | 45000 | $5.64 | 67,700.0000 | 0 | 198.24% | 0.00% |
| March 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Common Stock | 50900 | $0.00 | 122,955.0000 | 0 | 70.64% | 0.00% |
| March 2, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Common Stock | 35300 | $0.00 | 113,200.0000 | 0 | 45.31% | 0.00% |
| March 2, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Common Stock | 25966 | $0.00 | 139,166.0000 | 0 | 22.94% | 0.00% |
| March 2, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 106000 | $0.00 | 106,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 24800 | $0.00 | 69,967.0000 | 0 | 54.91% | 0.00% |
| March 2, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 15055 | $0.00 | 85,022.0000 | 0 | 21.52% | 0.00% |
| March 2, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 74400 | $0.00 | 74,400.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | O'Neill Gilmore Neil | CEO | A | Common Stock | 130700 | $0.00 | 260,869.0000 | 0 | 100.41% | 0.00% |
| March 2, 2024 | O'Neill Gilmore Neil | CEO | A | Common Stock | 72213 | $0.00 | 333,082.0000 | 0 | 27.68% | 0.00% |
| March 2, 2024 | O'Neill Gilmore Neil | CEO | A | Common Stock | 72212 | $0.00 | 405,294.0000 | 0 | 21.68% | 0.00% |
| March 5, 2024 | O'Neill Gilmore Neil | CEO | S | Common Stock | 77824 | $9.42 | 327,470.0000 | 0 | 19.20% | 0.00% |
| March 2, 2024 | O'Neill Gilmore Neil | CEO | A | Stock Option (right to buy) | 392100 | $0.00 | 392,100.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Common Stock | 19458 | $0.00 | 142,413.0000 | 0 | 15.83% | 0.00% |
| March 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Common Stock | 19457 | $0.00 | 161,870.0000 | 0 | 13.66% | 0.00% |
| March 4, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S | Common Stock | 20327 | $9.42 | 141,543.0000 | 0 | 12.56% | 0.00% |
| March 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 152800 | $0.00 | 152,800.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 103 | $10.90 | 74,791.0000 | 0 | 0.14% | 0.00% |
| Nov. 14, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 695 | $8.21 | 74,894.0000 | 0 | 0.92% | 0.00% |
| Nov. 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 139 | $8.40 | 75,589.0000 | 0 | 0.18% | 0.00% |
| Sept. 6, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 103 | $8.82 | 75,728.0000 | 0 | 0.14% | 0.00% |
| Aug. 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 702 | $8.59 | 75,831.0000 | 0 | 0.92% | 0.00% |
| Aug. 8, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 141 | $8.39 | 76,533.0000 | 0 | 0.18% | 0.00% |
| July 24, 2023 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 45167 | $0.00 | 45,167.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 135500 | $0.00 | 135,500.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S | Common Stock | 4317 | $8.80 | 72,055.0000 | 0 | 5.65% | 0.00% |
| June 5, 2023 | O'Neill Gilmore Neil | CEO | S | Common Stock | 6486 | $9.50 | 130,169.0000 | 0 | 4.75% | 0.00% |
| June 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 105 | $9.50 | 76,674.0000 | 0 | 0.14% | 0.00% |
| June 1, 2023 | Chatterjee Meeta | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Vaishnaw Akshay | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Hirsch Andrew | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Scadden David | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Reeve Emma | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Connaughton Bernadette | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Hopfield Jessica | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Common Stock | 77900 | $0.00 | 77,900.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 155800 | $0.00 | 155,800.0000 | 0 | 9999.99% | 0.00% |
| May 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 668 | $9.87 | 76,779.0000 | 0 | 0.86% | 0.00% |
| May 11, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 949 | $9.87 | 106,610.0000 | 0 | 0.88% | 0.00% |
| May 9, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 135 | $9.51 | 77,447.0000 | 0 | 0.17% | 0.00% |
| April 11, 2023 | Levy Elliott M. | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | O'Neill Gilmore Neil | CEO | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Eaton Bruce | EVP, CBO AND CTO | A | Common Stock | 16700 | $0.00 | 77,683.0000 | 0 | 27.38% | 0.00% |
| March 3, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 101 | $8.89 | 77,582.0000 | 0 | 0.13% | 0.00% |
| March 2, 2023 | Eaton Bruce | EVP, CBO AND CTO | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Common Stock | 31500 | $0.00 | 107,743.0000 | 0 | 41.32% | 0.00% |
| March 3, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 184 | $8.89 | 107,559.0000 | 0 | 0.17% | 0.00% |
| March 2, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 94500 | $0.00 | 94,500.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Common Stock | 18000 | $0.00 | 76,372.0000 | 0 | 30.84% | 0.00% |
| March 2, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | O'Neill Gilmore Neil | CEO | A | Common Stock | 50000 | $0.00 | 136,655.0000 | 0 | 57.70% | 0.00% |
| Feb. 13, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 3307 | $9.67 | 60,983.0000 | 0 | 5.14% | 0.00% |
| Feb. 13, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 4287 | $9.67 | 76,243.0000 | 0 | 5.32% | 0.00% |
| Feb. 13, 2023 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2790 | $9.67 | 65,559.0000 | 0 | 4.08% | 0.00% |
| Feb. 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | S | Common Stock | 346 | $11.10 | 64,290.0000 | 0 | 0.54% | 0.00% |
| Jan. 10, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 1752 | $8.16 | 80,530.0000 | 0 | 2.13% | 0.00% |